<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Biennial screening for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> using faecal occult blood testing has been shown to reduce the relative risk of mortality from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The Norwich screening centre commenced screening in July 2006 and so far has diagnosed over 350 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We compared the stage at diagnosis and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific mortality and survival in patients diagnosed through screening with a cohort of symptomatic patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> within the same age range </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: A comparative analysis was undertaken of <z:hpo ids='HP_0000001'>all</z:hpo> screen-detected <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients diagnosed between July 2006 and December 2010, with an age-matched group of patients diagnosed in the Norfolk and Norwich Hospital through the 2-week suspected <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> guidelines </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Three hundred and fifty-six cases of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were diagnosed through the screening programme, in patients with an age range of 60-79 years </plain></SENT>
<SENT sid="5" pm="."><plain>In the same time period, 292 patients in the same age range were diagnosed with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> through the 2-week suspected <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> pathway </plain></SENT>
<SENT sid="6" pm="."><plain>Sixteen patients in the screening group had evidence of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> at presentation compared with 62 in the symptomatic group (χ(2) , P&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>The proportion of T1/T2 and Dukes A <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> was significantly greater in the screening group (χ(2) , P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>There were 21 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo> in the screening group compared with 66 in the symptomatic group </plain></SENT>
<SENT sid="9" pm="."><plain>Survival analysis curves showed significantly better survival in the screening group (log-rank analysis P&lt;0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Screening for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> identifies <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> at a significantly earlier stage than in symptomatic patients, with subsequent improvement in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival </plain></SENT>
</text></document>